If you sell anything packaged in the EU, the clock is ticking, and it’s getting louder by the day. The Packaging and Packaging Waste Regulation...
Introducing Slate 2.0: Make Discovery More Inevitable and Less Accidental.
See What’s New
Insights on R&D innovation, emerging technologies, competitive strategy, and strategic decision-making.
If you sell anything packaged in the EU, the clock is ticking, and it’s getting louder by the day. The...
For 30 years, salmon was the only PDRN source that mattered clinically. That assumption just broke. A December 2025 clinical...
PDRN has become one of the most watched ingredients in regenerative skincare and aesthetic medicine. For years, the competition was...
The hydrogen economy was supposed to be driving a new wave of thermal component R&D and AI infrastructure was supposed...
The technical barriers that capped protein density at 15% have been dismantled. Arla, Fonterra, and Leprino are re-engineering the molecular...
CRISPR-modified fermentation strains claiming 60–70% reductions in substrate costs are appearing in the patent record. If those claims hold at...
Bridgestone, Milwaukee Electric, and Smart Tire are all independently moving toward “spoke contact” mechanisms where adjacent spokes engage to share...
Cultured meat’s biggest player isn’t building toward whole-tissue cultivation anymore, and that changes everything downstream. Across the innovations in food...
33% of all PDRN innovations filed in the last 12 months claim non-marine sources. Three years ago, that number was...
If you sell anything packaged in the EU, the clock is ticking, and it’s getting louder by the day. The Packaging and Packaging Waste Regulation...
For 30 years, salmon was the only PDRN source that mattered clinically. That assumption just broke. A December 2025 clinical study confirmed that low-molecular-weight peony...
PDRN has become one of the most watched ingredients in regenerative skincare and aesthetic medicine. For years, the competition was straightforward: who had the purest...
Two 2026 academic studies gave the cosmeceutical industry the proof it had been waiting on for years: PDRN can cross the stratum corneum. One study...
Over 90% of products marketed as “probiotic” cosmetics contain no live microorganisms. Instead, they deliver postbiotics lysates, ferments, metabolites without disclosing this substitution to consumers...
Around 12% of U.S. adults have used a GLP-1 drug such as semaglutide, tirzepatide, or a similar medication, and about 6% are using one today....
More than 35% of new skincare launches in 2024 used probiotics, prebiotics, or postbiotics. Barrier repair and hydration made up about 41% of microbiome cosmetic...
Over 40% of 2024 skincare launches featured microbiome-related ingredients. Yet approximately 90% of products labeled as “probiotic” actually contain postbiotics (ferments, lysates, filtrates) with no...
Cosmetic R&D teams are being asked to build skin microbiome portfolios while one core question remains unresolved: do barrier repair products need live bacteria, or...
An estimated 15 million U.S. adults currently use GLP-1 receptor agonist medications such as semaglutide and tirzepatide, with that figure projected to reach 30 million...
Get a demo and explore how leading R&D teams use Slate to streamline discovery, stay ahead of competitors, and drive innovation.
